Chikungunya
📧 Sign up to get email alerts when something new happens for Chikungunya.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) [Phase 2]
Phase 2 open-label study of alum-adjuvanted chikungunya virus-like particle vaccine PXVX0317 completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) [Phase 3]
Phase 3 trial of the VLP-based chikungunya vaccine PXVX0317 has completed and results have been posted. Sponsor Bavarian Nordic conducted th…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants [Phase 1]
A Phase 1 trial in healthy adults evaluated the safety, tolerability, and immunogenicity of VAL-181388 for chikungunya. The study results ha…
-
EMA approval · 2024-05-31First vaccine to protect adults from Chikungunya
EMA announced Ixchiq, the first chikungunya vaccine for adults, is being assessed under the OPEN framework to promote global public health.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating [NA]
Colombia-based clinical trial evaluating an insecticidal coating applied at vector breeding sites to sustainably reduce dengue and related a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents [Phase 3]
Phase 3 multicenter study evaluating safety and immunogenicity of a live-attenuated chikungunya vaccine in adolescents; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
Completed trial update on sylvatic transmission of Zika, dengue, and chikungunya viruses in Thailand and Cambodia, sponsored by NIAID, with …
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area [Phase 2]
Phase 2 trial update for a live attenuated Chikungunya vaccine completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Chikungunya Arthritis in the Americas
The update notes the completion of a clinical trial investigating chikungunya arthritis in the Americas sponsored by George Washington Unive…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease [Phase 3]
A Phase 3 trial evaluated chloroquine for the treatment of chikungunya; the study was terminated.
-
CLINICAL_TRIALS research · 2015-07-28Clinical Trial Update: Study of the Prognostic Value of Musculoskeletal Ultrasound in Adults With Chikungunya
This clinical study investigates the prognostic value of musculoskeletal ultrasound in adults with chikungunya, though its current status is…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins [Phase 1, Phase 2]
Phase 1/2 clinical evaluation of anti-Chikungunya virus hyperimmune intravenous immunoglobulin for Chikungunya infection; the trial status i…